Ansari Aseem Z. 13D/13G Filings for Design Therapeutics, Inc. (DSGN)

Ansari Aseem Z. 13D and 13G filings for Design Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-09
4:32 pm
Purchase
2021-12-31 13G Design Therapeutics, Inc.
DSGN
Ansari Aseem Z. 7,668,711
13.800%
7,668,711increase
(New Position)
Filing